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the stem without adjunctive balloon dilation. The Palmaz-Schatz stents warn 
implanted using a non-compliant be[Icon with a mean inflation pressure of 
12 ATM. The cross sectional area of the stem and lumen were measured by 
intravasCUlar ultrasound immediately and at 28 days after implant. 
Slant area (ram 2) 
tmptant 28 Days 
Nitinol 7.75 :t: 1.40 9.1U 4- 0.99* 
Palmaz.Schatz 6.94.4-1 A7 8,82 ± 1.19 
*p = 0,01 vemus Palmaz-Schatz 
At 28 days, the lumen area (ram 2) in the nifinol slants (7.P~2 4. 0.89) was 
significantly gmatsr than the Palmaz-SchaLz Slants (5.54 =l: 1.32, p = 0.046). 
On histOlogy, the vessel fn|uw score was similar for the nitirml (0.6 4. 0.3) and 
the Palmaz-Schalz (0.5 ± 0.1, p = 0,73) etents. The mean neoinflmal area 
(1.07 4. 0.44 turn ~ vsmus 2.07 :E 0.26 mm 2, p = 0.002) and percent area 
stsnos/s (17.0 4- 7.3 versus 35.2 4- 6,0, p = 9.003) ware significantly lees in 
the nitincl versus the Palmaz-Schatz stsnts. 
This nitinol self-expanding stem exerts a more favorable effect on vascalar 
remodeling and neointimai formation than a balloon expandable tubular slot- 
ted stem, thus optimizing the effects of stsnt placement in this expedmentsl 
model. 
~ Quantitative Evaluation of  the New Angiographlc 
Micro Stent 
Stsfan Verheye, William Wijns, Bernard De Bruyne, Chdstophe Bsauloyo, 
Guy R. Heynddckx. Cardiovascular Center, Aalst, BE 
Since October 1994,113 AVE Micro Stenfs (MS) were implanted for treatment 
of 95 lesions (out of 100) in 94 patients (pts), 89 m~e, mean age 62 4. f0 
(range 36--86). Five lesions could not be slanted because of poor guiding 
support (1), calcification (2) or angulation (2). Target vessels were LAD 
(38%), circumflex (17%), RCA (39%), LM (1%) and vein graft (5%). ME; 
of 4 (13%), 8 (43%) and 16 mm (44%) with diameters of 3.0 (60%), 3.5 
(34%) and 4.0 mm (6%) were delivered through 7F guiding catheters, High 
pressure inflation (mean 11 :E 2 bar, range 5-18) was used to fully expand 
the MS by tiuo,"oscopy and angiography. Indications were: elective (22°/o), 
optimization after PTCA (25%), non occlusive diSSection (41%), bail-out after 
PTCA (7%) and bait-out after usa of another etent (4%). Quantitative coronary 
angiogrephy (OCA) was performed in 58 lesions pre-PTCA, dudng balloon 
inflation, POst-PTCA, dudng MS-baUoon inflation and post-stem (Figure). The 
reference diameter was 2,9 4. 0.6 mm and the final diameter stonosis was 9 
4.12%. No anticoagulation was used in 87% of the pts (aspirin, fraclionatod 
Ilepadn for 2 weeks and ticlopidine for 1 month). Them were no access site 
complications (transfusions in 2 pls). Subacute stem thrombosis occurred 
in 1 pt 72 hours after MS implantation. Them were no death, myocardial 
Infarction or CABG. 
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Thus, no antlcoagulatlon isrequired following MS implantation, even in pts 
st higher dsk for (sub) acute slant thrombosis, Optimal slant deployment can 
be achieved with QCA on-line, but without intravascular ultrasound given the 
radiepacity of MS, 
~ InlUal Clinical Experience With a New Handmade 
Coronary Stent 
Ivan K. De Scheerder, Kal Wang, Pitsanu Kerdsinchal, Waiter Desmet, 
Jo Dens, Krzyszlof Wil~ek, Jan Van Humbeeck, Jan H. Piessens. 
University Hospital Gasthuisbsrg, Leuven, BE 
To reduce the cost of coronary stsntlng we handmade a balloon expandable 
stainless steel coil stem. Preliminary compadson with the Palmaz-Schalz 
StsM in porcine iliac artedas revealed no differences in the acute thrombosis 
rate nor in the 6 weeks foflow-up angiographiC and morphomstrio restenosis 
rate. Subsequently, 73 stems were implanted in coronary artedas of 52 pts 
(for bail-out in 28 pts and to improve a suboptimal angiogrephio rasuit in 24 
pts), Before stem implantation aspidn 500 mg IV and oral ticlopidin 500 mg 
was given in addition to hepadn to maintain the activated clotting time > 300 
eeC. After the stems were mounted by herod on tha balloon catheter used for 
predilation, all implantations were successful except for 2 : 1 stsnt was lost 
but could be retheved and in s sscond pt emsrgency bypass grafting was 
indicated. In the other pts flclopidin was continued for 2 months and aspidn 
320 mg for 6 months. There was no in-hospital stem thrombosis but 2 pts 
developed a groin hematoma, 1 necessitating blood transfusion. 
Conclusions: Implantation of a low cost serf made coronary stem gives 
excellent in-hospital results. The 6 months clinical and quantitative corenmy 
angiographic fallow-up results will be presented. 
~ Treatment of  Long Les ions in Tortuous Small 
Coronary Vessels With a New Intravascular 
Rigid-Flex (NIR) Slant 
Yamn Almagor, Kobi Richter, carlo DiMario, Akira Itoh, Luc~a~ DiFra~casco, 
Massing Ferrero, Luigi Malallo, Simonetta Blengino, Martin B. Leon, 
Antonio Colombo. Columbus Clinic, Milan, Italy; Shaare Zedek Medical 
Center, Jerusalem, Israel 
Stem designs favoring radial support and plaque scaffolding are nee, essanj 
to reduce restenosls but confer decreased flexibility, limiting use in complex 
lesion/veSSel anatomy. The balloon-expandable stainless steel NIR stont em- 
ploys a continuous uniform multlcallular design which has superior flexibility 
prior to expansion, but also achieves excellent support and scaffolding after 
deployment. To assess the utility of this advan~¢l stem design, 42 NIR slants 
of various lengths (10 = 9 ram, 17 = 16 ram, and 15 -= 32 ram) were implanted 
in 28 lesions (11 LAD, f 0 LCX, and 7 RCA) in 15 patients. Twenty-five les/ons 
(89%) were considered by two experienced operators difficult o treat with 
the conventional tubular slotted stem due to vessel tortuoaity (n = 7), distal 
lesion location (n = 6), lesion length (mean eteMed segment = 37 mm), and/or 
< 2.5 mm reference diameter (n = 11, mean reference diameter = 2.72 ± 
0.56 ram). Deployment success was 98%= (42/43 stants). High pressure stem 
expansion (17 4. 4 arm) was guided by intracomnary ultrasound (ICUS) in 
all cases. After final stem expansion, minimum lumen diameter was 2.47 :E 
0.5 mm (mean % stsnoais 9.2%°) and minimal cross-sectional area (ICUS) 
was 6.4 :E 0.2 mrr~ (distal reference area = 6.2 :t: 0,2 ram2). Post-proeedum, 
all patients warn treated with aspirin alone and at 30-day follow-up, there 
has been no etent thrombosis, In conclusion: Despite complex lesion/vessel 
anatomy, eady experiences with the NIR stem indicate favorable deployment 
success, acute anglographic results, and 30-day clinical outcomes. This new 
stem design has the IX3tsnflal to expand clinical indications and simplify the 
technique of coronary stsnt implantation. 
~ Comparison of  Initial and Late Angiographlc 
Results After AVE Micro and Palmaz-Schatz Stent 
Implantstion 
Shigaru Salto, George Hosokawa, Shinji Tanaka. Shonan Kamakura 
General Hospital, Kamakum, Japan 
To evaluate the initial and late outcome Of AVE introcoronapj m(cro slant 
implantation, we compared the results of 20 patients (23 lesions; AVE) of the 
implantation with those of 294 patients (324 lesions; P,S) of elective Palmaz- 
Sohetz Slant implantation. An0i~.~,~.,~,,ic feffow up was done 3 months (3M) 
after stem implantation. Them ware no significant differences in ~;eir age. 
gender, lesion types, extents Of o~seased Vesse!s or left ventricular ejeotion 
fraction between the 2 groups. 
AVE(N=2.3) PS (N = 324) p 
Delivery success 22 (96%) 296 (91%) NS 
Stent hrombosis 0 0 NS 
Reference diameter ( am) 3.14 ± 0.34 3.24 :E 0.78 NS 
MLD before slanting (ram) 0.87 ± 0.33 0.8g :k 0,54 NS 
MLD after stenting (ram) 3.01 + 0A0 3,24 -~ 0.79 N$ 
MLD at 3M (ram) 1.70.4-1.05 2.42 :E 1.18 <0.001 
% Stenosls at 3M 45,6 ::E 31.4 27,6 4- 24,2 <0.001 
Restenosls rate 9 (39%) 50 (20%) <0.01 
ReinterventioNCABG 6 (28%) 38 (13%) 0,06 
MLO; minimum lumen diameter 
Thus, the long-term results of AVE stem implantation, although its ini- 
tial results are acceptable, are inferior to those of Palmaz-Schatz stent. 
We conclude that AVE stoM implantation should be considered, only when 
Palmaz-Schalz stsnt is not feasible. 
~ First Use of  the Second-Generation 
Glanturco-Roubin Stent Without Coumedln 
Jean Marco, Jean Fa|adst, Phi[ippe Brunel, Christian Jordan, 
Bernard Cassagneau, Jean-Pierre Laurent. Ch'nlque Pasteur, Toulouse, 
France 
The second generation Giantureo-Roubin stsnt (GR li) has a lower profile, 
is available in longer lengths, and has a radioepaque marker at each end. 
To perform initial evaluation of th? modified etsnt, 27 GR if slants in 20 or 
40 mm lengMs were implanted in 1~ patients between May 23 and June 2, 
1995, All procedures were planned, although 3 patients experisncod acute 
closure following the initial angioplasty. A femoral approach (16 patients) or 
